YU41681B - Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids - Google Patents

Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids

Info

Publication number
YU41681B
YU41681B YU2867/79A YU286779A YU41681B YU 41681 B YU41681 B YU 41681B YU 2867/79 A YU2867/79 A YU 2867/79A YU 286779 A YU286779 A YU 286779A YU 41681 B YU41681 B YU 41681B
Authority
YU
Yugoslavia
Prior art keywords
alcaloids
dihydroergot
amorhous
ergot
ray
Prior art date
Application number
YU2867/79A
Other languages
English (en)
Other versions
YU286779A (en
Inventor
M Mohar
R Rucman
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Priority to YU2867/79A priority Critical patent/YU41681B/xx
Priority to PT72078A priority patent/PT72078B/pt
Priority to GB8037133A priority patent/GB2063864B/en
Priority to LU82945A priority patent/LU82945A1/de
Priority to ES496969A priority patent/ES496969A0/es
Priority to NL8006341A priority patent/NL8006341A/nl
Priority to BE0/202868A priority patent/BE886262A/fr
Priority to DE19803043832 priority patent/DE3043832A1/de
Priority to FR8024632A priority patent/FR2470133A1/fr
Priority to JP16343880A priority patent/JPS56164195A/ja
Publication of YU286779A publication Critical patent/YU286779A/xx
Publication of YU41681B publication Critical patent/YU41681B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU2867/79A 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids YU41681B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids
PT72078A PT72078B (en) 1979-11-22 1980-11-19 X-ray amorphous phisiologically acceptable acid addition salts of ergot alkaloids and dihidroergot alkaloids a process for the preparation thereof and their use in therapy
GB8037133A GB2063864B (en) 1979-11-22 1980-11-19 X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy
LU82945A LU82945A1 (de) 1979-11-22 1980-11-19 Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie
ES496969A ES496969A0 (es) 1979-11-22 1980-11-19 Sales acidas de adicion, amorfas a los rayos x,aceptables fisiologicamente,de alcaloides de la ergotina y alcaloides de la dihidroergotina, proceso para la preparacion de ellas y su uso terapeutico
NL8006341A NL8006341A (nl) 1979-11-22 1980-11-20 Voor roentgenstralen amorfe, fysiologisch toelaatbare zuuradditiezouten van ergotalkaloiden en dihydroer- gotalkaloiden, werkwijze voor de bereiding en toepas- sing daarvan in de therapie.
BE0/202868A BE886262A (fr) 1979-11-22 1980-11-20 Sels d'addition d'acides amorphes d'alcaloides de l'ergot et du dihydroergot, leur preparation et leur emploi
DE19803043832 DE3043832A1 (de) 1979-11-22 1980-11-20 Roentgenamorphe, physiologisch vertraegliche saeureadditionssalze von ergot- bzw. dihydroergotalkaloiden, verfahren zu deren herstellung sowie ihre verwendung in der therapie
FR8024632A FR2470133A1 (fr) 1979-11-22 1980-11-20 Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation
JP16343880A JPS56164195A (en) 1979-11-22 1980-11-21 Acid addition salt of ergot alkaloid and dihydro ergot alkaloid and manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids

Publications (2)

Publication Number Publication Date
YU286779A YU286779A (en) 1983-06-30
YU41681B true YU41681B (en) 1987-12-31

Family

ID=25558910

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids

Country Status (10)

Country Link
JP (1) JPS56164195A (es)
BE (1) BE886262A (es)
DE (1) DE3043832A1 (es)
ES (1) ES496969A0 (es)
FR (1) FR2470133A1 (es)
GB (1) GB2063864B (es)
LU (1) LU82945A1 (es)
NL (1) NL8006341A (es)
PT (1) PT72078B (es)
YU (1) YU41681B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87190A1 (fr) * 1988-04-06 1989-11-14 Wurth Paul Sa Machine de percage de trous de coulee d'un four a cuve

Also Published As

Publication number Publication date
NL8006341A (nl) 1981-06-16
YU286779A (en) 1983-06-30
GB2063864A (en) 1981-06-10
PT72078B (en) 1981-09-29
FR2470133A1 (fr) 1981-05-29
ES8205796A1 (es) 1982-08-01
FR2470133B3 (es) 1982-09-03
ES496969A0 (es) 1982-08-01
LU82945A1 (de) 1981-03-26
DE3043832A1 (de) 1981-09-17
JPS56164195A (en) 1981-12-17
GB2063864B (en) 1983-07-20
PT72078A (en) 1980-12-01
BE886262A (fr) 1981-03-16

Similar Documents

Publication Publication Date Title
DE3060592D1 (en) Derivatives of 2,4,6-triodo-isophthalic acid, process for their preparation and x-ray contrast agents containing them
DE3061347D1 (en) 2,4,6-triiodo-isophthalic acid derivatives, process for their preparation and x-ray contrast agents containing them
PT72079B (en) Process for the preparation of 7-acylamino-3-vinylcephalosporanic acid derivatives
GR65303B (en) Process for preparation of phthalazin-4-ylacetic acid derivatives
JPS52116492A (en) Alkyloxim derivative of novel 77aminothiazolylacetamide cephalospolanate process for preparing same and medical composition
IL60416A (en) Tri-iodised 5-aminoisophthalic acid derivatives,process for their preparation and x-ray contrast preparations comprising them
IL52023A (en) Process for the preparation of di-n-propyl-acetic acid and salts thereof
AR245133A1 (es) Procedimiento para la preparacion de sales por adicion de acidos de cefem cristalizados.
PT76523A (en) Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same
HK55284A (en) Unisaturated-thio-derivatives of 7-acetamido-3-cephem-4-carboxylic acid and process for their preparation
IL61179A (en) 2-amino-4-substituted-5-thiazole-carboxylic acid derivatives and process for their preparation
YU41681B (en) Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids
DE2862327D1 (en) Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
HU178306B (en) Process for preparing pharmaceutically active /omega-amino-alkoxy/-dibenzyl derivatives and acid addition salts thereof
IL51057A0 (en) Thiadiazolyl derivatives of 7-acylamido-3-cephem-4-carboxylic acid and process for their preparation
DE2860609D1 (en) Bis-azido-phthalic acid derivatives and process for their preparation
GB2047243B (en) Preparing derivatives of 6 - amidino - penicillanic acid
PH17465A (en) Substituted pirrolidinyl-benzoic acid derivatives and a process for their preparation and pharmaceutical formulation
GR63662B (en) Piperazinecarbodithioic acid derivatives process for their preparation and pharmaceutical compositions containing them
GB2006763B (en) Derivatives of 4-cyclohexyl-1-naphtaleneacetic acid process for their preparation and their use as drugs
DE3062347D1 (en) Process for the preparation of derivatives of clavulanic acid
ZA806375B (en) Derivatives of clavulanic acid,a process for their preparation and their use
EG15047A (en) Process for preparing of substituted b-carbolin-3-carboxylic acid derivatives
IL62063A (en) Process for the preparation of di-n-propyl-acetic acid and salts thereof
YU52776A (en) Process for obtaining ergosine and physiologically acceptable acid addition salts thereof